Coagulation abnormalities in cyanotic heart disease.
D000614:Aminocaproates / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000209:etiology*; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy / Q000209:etiology; D005342:Fibrinolysis; D006330:Heart Defects, Congenital / Q000150:complications*; D006400:Hematocrit; D006493:Heparin / Q000627:therapeutic use; D006801:Humans
D000614:Aminocaproates; D006493:Heparin